Cresset Asset Management LLC Raises Position in HCA Healthcare, Inc. $HCA

Cresset Asset Management LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 52.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,141 shares of the company’s stock after purchasing an additional 1,425 shares during the period. Cresset Asset Management LLC’s holdings in HCA Healthcare were worth $1,765,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Clearstead Trust LLC lifted its holdings in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in HCA Healthcare in the second quarter worth about $40,000. Compound Global Advisors LLC purchased a new position in HCA Healthcare in the 3rd quarter worth about $44,000. Finally, True Wealth Design LLC lifted its holdings in shares of HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after buying an additional 70 shares during the period. Institutional investors own 62.73% of the company’s stock.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst sentiment and research upgrades: several outlets and analysts continue to rate HCA favorably — one consensus snapshot called the stock a “Moderate Buy,” reflecting continued analyst confidence that HCA can grow earnings and return capital to shareholders. Article Title
• Positive Sentiment: Long-term demographic bull case: MarketBeat argues HCA is a likely beneficiary of U.S. aging demographics, noting management’s strong guidance (FY2026 EPS and EBITDA ranges), expanded capex, a $10B repurchase authorization and a raised dividend — all supportive of long‑term growth and shareholder returns. Article Title
• Neutral Sentiment: Analyst estimate tweaks from Zacks: Zacks Research nudged near‑term EPS estimates slightly higher for Q2, Q3 and Q4 2026 and raised FY2026 to $29.63, which supports the earnings outlook, but it kept a “Hold” rating — a modest positive but not a strong endorsement. Article Title
• Neutral Sentiment: Zacks’ view is mixed farther out: while FY2026 estimates were lifted, Zacks trimmed its FY2028 EPS forecast modestly — a sign analysts see near‑term strength but some uncertainty on longer‑term margin expansion. Article Title
• Neutral Sentiment: Local/industry headlines are mixed and mostly non‑company specific: a local hospital (Manchester’s Catholic Medical Center) plans to end outpatient mental‑health services and a leadership hire at Methodist Healthcare were reported — signals about regional capacity and staffing but with limited direct impact on HCA’s large national footprint. Article Title Article Title
• Negative Sentiment: Near‑term policy and revenue risks remain prominent: recent company commentary and market writeups note revenue growth was slightly below expectations in the prior quarter and management flagged $600–$900M of potential EBITDA headwinds from insurance‑exchange changes plus state supplemental payment declines — factors that could cap near‑term upside despite strong EPS. Article Title

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 15,214 shares of company stock valued at $7,797,595 in the last quarter. Corporate insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on HCA. Royal Bank Of Canada upped their target price on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. TD Cowen restated a “buy” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a report on Friday, January 30th. KeyCorp set a $503.00 target price on HCA Healthcare in a report on Wednesday, January 28th. Finally, Barclays boosted their target price on shares of HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $534.50.

HCA Healthcare Stock Down 0.2%

HCA stock opened at $533.63 on Monday. HCA Healthcare, Inc. has a 52 week low of $310.18 and a 52 week high of $552.90. The firm has a 50-day simple moving average of $500.34 and a 200-day simple moving average of $465.79. The stock has a market capitalization of $119.33 billion, a P/E ratio of 18.80, a P/E/G ratio of 1.64 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter last year, the business posted $6.22 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.15%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.